Neuronal loss in Pelizaeus-Merzbacher disease differs in various mutations of the proteolipid protein 1.
Mutations affecting proteolipid protein 1 (PLP1), the major protein in central nervous system myelin, cause the X-linked leukodystrophy Pelizaeus-Merzbacher disease (PMD). We describe the neuropathologic findings in a series of eight male PMD subjects with confirmed PLP1 mutations, including duplications, complete gene deletion, missense and exon-skipping. While PLP1 mutations have effects on oligodendrocytes that result in mutation-specific degrees of dysmyelination, our findings indicate that there are also unexpected effects in the central nervous system resulting in neuronal loss. Although length-dependent axonal degeneration has been described in PLP1 null mutations, there have been no reports on neuronal degeneration in PMD patients. We now demonstrate widespread neuronal loss in PMD. The patterns of neuronal loss appear to be dependent on the mutation type, suggesting selective vulnerability of neuronal populations that depends on the nature of the PLP1 disturbance. Nigral neurons, which were not affected in patients with either null or severe misfolding mutations, and thalamic neurons appear particularly vulnerable in PLP1 duplication and deletion patients, while hippocampal neuronal loss was prominent in a patient with complete PLP1 gene deletion. All subjects showed cerebellar neuronal loss. The patterns of neuronal involvement may explain some clinical findings, such as ataxia, being more prominent in PMD than in other leukodystrophies. While the precise pathogenetic mechanisms are not known, these observations suggest that defective glial functions contribute to neuronal pathology.
Sima
Anders A F
AA
Department of Pathology, School of Medicine, Wayne State University, Detroit, MI, USA.
Pierson
Christopher R
CR
Woltjer
Randall L
RL
Hobson
Grace M
GM
Golden
Jeffrey A
JA
Kupsky
William J
WJ
Schauer
Galen M
GM
Bird
Thomas D
TD
Skoff
Robert P
RP
Garbern
James Y
JY
D000328:Adult; D000367:Age Factors; D001921:Brain / Q000473:pathology*; D016923:Cell Death / Q000235:genetics*; D041321:Chromosomes, Human, X; D005819:Genetic Markers; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D009154:Mutation; D018991:Myelin Proteolipid Protein / Q000235:genetics*; D009186:Myelin Sheath / Q000235:genetics / Q000473:pathology; D009457:Neuroglia / Q000473:pathology; D009474:Neurons / Q000473:pathology*; D020371:Pelizaeus-Merzbacher Disease / Q000235:genetics* / Q000473:pathology*
D005819:Genetic Markers; D018991:Myelin Proteolipid Protein; C472930:PLP1 protein, human